Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Cell Death & Disease|April 16, 2021
Malignant pleural mesothelioma co-opts BCL-XL and autophagy to escape apoptosisDuo Xu, Shun-Qing Liang, Zhang Yang, et al.Scientific Reports|August 6, 2024
Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatmentDarya Karatkevich, Tereza Losmanova, Philipp Zens, et al.Theranostics|May 13, 2022
Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinomaHaitang Yang, Beibei Sun, Liwen Fan, et al.Cancer Immunology, Immunotherapy : CII|October 5, 2023
An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1Haibin Deng, Huixiang Ge, Christelle Dubey, et al.Cancer Research|March 9, 2021
CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1-Amplified Lung CancerZhang Yang, Shun-Qing Liang, Haitang Yang, et al.Cell Death and Differentiation|December 6, 2024
Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancerLiang Zhao, Haibin Deng, Jingyi Zhang, et al.Journal of Experimental & Clinical Cancer Research : CR|April 20, 2021
Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5'-deoxy-5-fluorocytidine (5'-DFCR)Yanyun Gao, Philipp Zens, Min Su, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|July 30, 2020
EpCAM+CD73+ mark epithelial progenitor cells in postnatal human lung and are associated with pathogenesis of pulmonary disease including lung adenocarcinomaLimei Wang, Patrick Dorn, Cedric Simillion, et al.Clinical and Translational Medicine|March 31, 2025
Transitional CXCL14+ cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinomaWeijiao Xu, Haitang Yang, Ke Xu, et al.EMBO Molecular Medicine|August 9, 2021
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancerZhang Yang, Shun-Qing Liang, Maria Saliakoura, et al.Pageof 7